electroCore, Announced The U.S. Patent And Trademark Office Has Issued A Patent Related To A System For Stimulating A Nerve Target In The Head Or Neck Of A Patient For Treatment Of Various Disorders, Such As Primary Headache
Portfolio Pulse from Benzinga Newsdesk
electroCore has been granted U.S. Patent No. 11,839,764 for a system that uses electrical stimulation to treat medical conditions such as primary headaches. The system includes software on a mobile device to control the electrical impulses delivered by a stimulator targeting nerves in the head or neck.
December 12, 2023 | 1:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
electroCore has received a patent for a nerve stimulation system, potentially enhancing its product portfolio and market position in medical devices for headache treatment.
The issuance of a new patent typically strengthens a company's intellectual property portfolio, which can lead to increased investor confidence and potential market expansion. For electroCore, this patent may provide a competitive edge in the medical device sector for headache treatments, likely resulting in a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100